PatientsVille.com Logo

PatientsVille

Kenalog Side Effects

Common Kenalog Side Effects


The most commonly reported Kenalog side effects (click to view or check a box to report):

Injection Site Atrophy (126)
Injection Site Reaction (75)
Headache (52)
Injection Site Pain (46)
Endophthalmitis (46)
Pain (44)
Injection Site Discolouration (43)
Arthralgia (37)
Nausea (37)
Muscle Atrophy (36)
Dizziness (36)
Depression (32)
Insomnia (32)
Anxiety (29)
Menorrhagia (28)
Flushing (27)
Alopecia (26)
Pruritus (26)
Menstruation Irregular (25)
Skin Discolouration (25)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Kenalog Side Effects Reported to FDA

The following Kenalog reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Kenalog on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Muscle Disorder
This is a report of a 17-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Kenalog Inj (dosage: 1df: 1inj, start time: Dec 05, 2013), combined with:
  • Zyrtec
and developed a serious reaction and side effect(s). The consumer presented with:
  • Muscle Disorder
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenalog Inj treatment in female patients, resulting in muscle disorder side effect.

Injection Site Atrophy
This report suggests a potential Kenalog Injection Site Atrophy side effect(s) that can have serious consequences. A 26-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: hypersensitivity and used Kenalog (dosage: NA) starting Dec 18, 2013. Soon after starting Kenalog the patient began experiencing various side effects, including:
  • Injection Site Atrophy
Drugs used concurrently: NA. Although Kenalog demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as injection site atrophy, may still occur.

Paraesthesia, Dizziness, Herpes Zoster, Depression, Injection Site Atrophy
This Paraesthesia, Dizziness, Herpes Zoster, Depression, Injection Site Atrophy problem was reported by a consumer or non-health professional from US. A 31-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: dermatitis contact,dermatitis allergic. On NS this consumer started treatment with Kenalog (dosage: Injection). The following drugs were being taken at the same time: NA. When commencing Kenalog, the patient experienced the following unwanted symptoms/side effects:
  • Paraesthesia
  • Dizziness
  • Herpes Zoster
  • Depression
  • Injection Site Atrophy
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as paraesthesia, may become evident only after a product is in use by the general population.

Menorrhagia, Menstrual Disorder
This is a report of a 46-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: arthritis and was treated with Kenalog 40mg Bristol Meyers (dosage: One Time Into The Muscle) starting Dec 23, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Menorrhagia
  • Menstrual Disorder
This opens a possibility that Kenalog 40mg Bristol Meyers treatment could cause the above reactions, including menorrhagia, and some female subjects may be more susceptible.


Diabetic Ketoacidosis
A 74-year-old male patient (weight: NA) from US with the following symptoms/conditions: arthralgia started Kenalog-40 Inj treatment (dosage: On Both Shoulders.) on NS. Soon after starting Kenalog-40 Inj treatment, the subject experienced various side effects, including:
  • Diabetic Ketoacidosis
Concurrently used drugs:
  • Amlodipine
  • Nortriptyline Hcl
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Kenalog-40 Inj.

Arthritis, Musculoskeletal Pain
A 70-year-old male patient from GB (weight: NA) experienced symptoms, such as: rotator cuff syndrome and was treated with Kenalog Inj(dosage: NA). The treatment was initiated on Jan 02, 2014. After that a consumer reported the following side effect(s):
  • Arthritis
  • Musculoskeletal Pain
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Kenalog Inj efficacy:
  • Normal Saline
  • Warfarin
  • Metformin
  • Paroxetine
  • Bisoprolol
  • Simvastatin
  • Pregabalin
  • Lansoprazole
The patient was hospitalized.

Arthralgia, Injection Site Paraesthesia, Injection Site Atrophy, Injection Site Hypoaesthesia, Pain In Extremity
In this report, Kenalog Inj was administered for the following condition: influenza like illness.A 55-year-old female consumer from US (weight: NA) started Kenalog Inj treatment (dosage: NA) on 201208.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Arthralgia
  • Injection Site Paraesthesia
  • Injection Site Atrophy
  • Injection Site Hypoaesthesia
  • Pain In Extremity
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Kenalog Inj treatment could be related to the listed above side effect(s).

Swelling Face, Insomnia, Feeling Abnormal, Confusional State, Vaginal Haemorrhage, Depression, Mood Altered, Abnormal Behaviour
This is a report of the following Kenalog side effect(s):
  • Swelling Face
  • Insomnia
  • Feeling Abnormal
  • Confusional State
  • Vaginal Haemorrhage
  • Depression
  • Mood Altered
  • Abnormal Behaviour
A 44-year-old female patient from US (weight: NA) presented with the following condition: asthma and received a treatment with Kenalog (dosage: NA) starting: Jan 02, 2014.The following concurrently used drugs could have generated interactions:
  • Budesonide
  • Budesonide
  • Budesonide
  • Prednisone
  • Albuterol Inhaler
  • Motrin
  • Guafenisen/codeine
  • Tessalon Perl
This report suggests that a Kenalog treatment could be associated with the listed above side effect(s).

Injection Site Atrophy, Injection Site Scar
This Kenalog report was submitted by a 34-year-old female consumer from US (weight: NA). The patient was diagnosed with: upper respiratory tract inflammation and Kenalog was administered (dosage: Given Into/under The Skin) starting: NS. The consumer developed a set of symptoms:
  • Injection Site Atrophy
  • Injection Site Scar
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Kenalog treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pelvic Pain, Arthralgia, Motor Dysfunction, Atrophy, Palpitations, Hypertension, Hyperhidrosis, Migraine, Abdominal Discomfort
This is a report of a possible correlation between Kenalog Inj use and the following symptoms/side effect(s):
  • Pelvic Pain
  • Arthralgia
  • Motor Dysfunction
  • Atrophy
  • Palpitations
  • Hypertension
  • Hyperhidrosis
  • Migraine
  • Abdominal Discomfort
which could contribute to an assessment of Kenalog Inj risk profile.A 31-year-old female consumer from US (weight: NA) was suffering from NA and was treated with Kenalog Inj (dosage: NA) starting 201310.Other concurrent medications: NA.

Lipoatrophy, Tendon Rupture
A 29-year-old female patient from DK (weight: NA) presented with the following symptoms: arthritis,local anaesthesia and after a treatment with Kenalog Inj (dosage: NA) experienced the following side effect(s):
  • Lipoatrophy
  • Tendon Rupture
The treatment was started on Nov 24, 2010. Kenalog Inj was used in combination with the following drugs:
  • Lidocaine
This report could alert potential Kenalog Inj consumers.

Injection Site Atrophy, Glucose Tolerance Impaired, Nerve Injury, Skin Atrophy, Feeling Abnormal, Dizziness, Weight Decreased, Malaise, Hypoaesthesia
In this report, a 53-year-old female patient from US (weight: NA) was affected by a possible Kenalog side effect.The patient was diagnosed with hypersensitivity,rhinorrhoea. After a treatment with Kenalog (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Injection Site Atrophy
  • Glucose Tolerance Impaired
  • Nerve Injury
  • Skin Atrophy
  • Feeling Abnormal
  • Dizziness
  • Weight Decreased
  • Malaise
  • Hypoaesthesia
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Kenalog treatment.

Meningitis, Immune System Disorder, Sexual Dysfunction
This is a report of a 45-year-old male patient from US (weight: NA), who used Kenalog (dosage: NA) for a treatment of intervertebral disc protrusion. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Meningitis
  • Immune System Disorder
  • Sexual Dysfunction
The following drugs could possibly have interacted with the Kenalog treatment
  • Dexamethasone
Taken together, these observations suggest that a Kenalog treatment could be related to side effect(s), such as Meningitis, Immune System Disorder, Sexual Dysfunction.

Injection Site Atrophy
This injection site atrophy side effect was reported by a pharmacist from US. A 2-year-old male patient (weight:NA) experienced the following symptoms/conditions: dermatitis contact. The patient was prescribed Kenalog (dosage: NA), which was started on Jul 11, 2013. Concurrently used drugs: NA. When starting to take Kenalog the consumer reported the following symptoms:
  • Injection Site Atrophy
These side effects may potentially be related to Kenalog.

Injection Site Reaction, Injection Site Atrophy, Back Pain, Pain In Extremity, Muscle Atrophy, Nerve Injury
This is a Kenalog side effect report of a 43-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Kenalog (dosage:1 Dose, Gluteus Maximus, start time: Feb 28, 2013), combined with:
  • Wellbutrin
  • Xopenex 45
, and developed a serious reaction and a injection site reaction side effect. The patient presented with:
  • Injection Site Reaction
  • Injection Site Atrophy
  • Back Pain
  • Pain In Extremity
  • Muscle Atrophy
  • Nerve Injury
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Kenalog treatment in female patients suffering from NA, resulting in injection site reaction.

Arthralgia, Fungal Infection
This report suggests a potential Kenalog-40 Inj arthralgia side effect(s) that can have serious consequences. A 68-year-old male patient from COUNTRY NOT SPECIFIED (weight:NA) was diagnosed with the following health condition(s): osteoarthritis and used Kenalog-40 Inj (dosage: NA) starting NS. Soon after starting Kenalog-40 Inj the patient began experiencing various side effects, including:
  • Arthralgia
  • Fungal Infection
Drugs used concurrently:
  • Lidocaine (1df=2%-units Nos)
  • Bupivacaine (1df=0.25%-units Nos)
The patient was hospitalized. Although Kenalog-40 Inj demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as arthralgia, may still occur.

Ocular Hyperaemia, Retinal Haemorrhage, Retinal Detachment
This ocular hyperaemia problem was reported by a consumer or non-health professional from US. A 33-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): inflammation.On Feb 16, 2011 a consumer started treatment with Kenalog-40 (dosage: 200 Mg Per 5 Ml). The following drugs/medications were being taken at the same time: NA. When commencing Kenalog-40, the patient experienced the following unwanted symptoms /side effects:
  • Ocular Hyperaemia
  • Retinal Haemorrhage
  • Retinal Detachment
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as ocular hyperaemia, may become evident only after a product is in use by the general population.

Pain, Headache, Dizziness
This is a Kenalog side effect report of a 56-year-old patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Kenalog (dosage: NA) starting Sep 18, 2013. Concurrently used drugs:
  • Cytomedrol
  • Xopenex
Soon after that, the consumer experienced the following of symptoms:
  • Pain
  • Headache
  • Dizziness
This opens a possibility that Kenalog could cause pain and that some patients may be more susceptible.

Abdominal Pain Upper, Sinusitis, Presyncope
A 63-year-old female patient (weight: NA) from US with the following symptoms: sinusitis started Kenalog treatment (dosage: NA) on Aug 28, 2013. Soon after starting Kenalog treatment, the consumer experienced several side effects, including:
  • Abdominal Pain Upper
  • Sinusitis
  • Presyncope
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Kenalog side effects, such as abdominal pain upper.

Cushingoid, Contusion, Skin Atrophy, Alopecia, Frustration
This cushingoid side effect was reported by a consumer or non-health professional from US. A 56-year-old female patient (weight:NA) experienced the following symptoms/conditions: morton^s neuralgia.The patient was prescribed Kenalog-40 Inj (dosage: NA), which was started on NS. Concurrently used drugs: NA..When starting to take Kenalog-40 Inj the consumer reported symptoms, such as:
  • Cushingoid
  • Contusion
  • Skin Atrophy
  • Alopecia
  • Frustration
These side effects may potentially be related to Kenalog-40 Inj.

Injection Site Atrophy
This is a report of a 42-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: rash, who was treated with Kenalog (dosage: 1x Only, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Injection Site Atrophy
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kenalog treatment in female patients, resulting in injection site atrophy side effect.

Urticaria
This report suggests a potential Kenalog-40 Inj Urticaria side effect(s) that can have serious consequences. A 60-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: arthritis and used Kenalog-40 Inj (dosage: NA) starting 201304. Soon after starting Kenalog-40 Inj the patient began experiencing various side effects, including:
  • Urticaria
Drugs used concurrently:
  • Lidocaine
  • Flomax
  • Diclofenac
Although Kenalog-40 Inj demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as urticaria, may still occur.

Injection Site Discolouration, Injection Site Atrophy, Injection Site Pain
This Injection Site Discolouration, Injection Site Atrophy, Injection Site Pain problem was reported by a consumer or non-health professional from US. A 26-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: prophylaxis. On Jan 28, 2013 this consumer started treatment with Kenalog-40 Inj (dosage: Site Of Inj: Right Cheek, Right Below The Hip Bone.). The following drugs were being taken at the same time:
  • Bactrim
When commencing Kenalog-40 Inj, the patient experienced the following unwanted symptoms/side effects:
  • Injection Site Discolouration
  • Injection Site Atrophy
  • Injection Site Pain
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as injection site discolouration, may become evident only after a product is in use by the general population.

Influenza, Injection Site Atrophy
This is a report of a 52-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Kenalog-40 Inj (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Influenza
  • Injection Site Atrophy
This opens a possibility that Kenalog-40 Inj treatment could cause the above reactions, including influenza, and some female subjects may be more susceptible.

Skin Atrophy, Off Label Use
A 45-year-old female patient (weight: NA) from US with the following symptoms/conditions: upper respiratory tract infection,influenza started Kenalog-40 Inj treatment (dosage: One Time Dose) on Dec 28, 2012. Soon after starting Kenalog-40 Inj treatment, the subject experienced various side effects, including:
  • Skin Atrophy
  • Off Label Use
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Kenalog-40 Inj.

1 of 37 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Kenalog Side Effects

    Did You Have a Kenalog Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Kenalog for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Kenalog Safety Alerts, Active Ingredients, Usage Information

    NDC0003-0293
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameKENALOG-40
    NameTRIAMCINOLONE ACETONIDE
    Dosage FormINJECTION, SUSPENSION
    RouteINTRA-ARTICULAR; INTRAMUSCULAR
    On market since20090601
    LabelerE.R. Squibb & Sons, L.L.C.
    Active Ingredient(s)TRIAMCINOLONE ACETONIDE
    Strength(s)40
    Unit(s)mg/mL
    Pharma Class

    Kenalog Dosage, Warnings, Usage.

    Side Effects reported to FDA: 909

    Kenalog safety alerts: No

    Reported deaths: 9

    Reported hospitalizations: 78

    Latest Kenalog clinical trials